Cyanvac Llc

This study tests a new COVID vaccine given as a single nasal spray. It aims to see if the spray is safe and boosts the body's immune defenses against the virus. About 227 healthy adults aged 18 to 80 are taking part. The vaccine is designed to work where the virus enters the body…

This study compares a single-dose nasal spray COVID-19 vaccine (CVXGA) to a standard mRNA shot (Comirnaty) in about 432 healthy adults who have already had a primary COVID-19 vaccine series. The goal is to see if the nasal vaccine is safer and better at preventing symptomatic COV…

This early-stage trial tests two new nasal spray vaccines (CVM150 and CVM26) designed to prevent mumps. About 60 healthy adults aged 18-29 will receive one of the vaccines to check for side effects and measure immune response. The goal is to find a safer, easier-to-use alternativ…